Bio-Techne (TECH) revenue breakdown
By segment, Protein Sciences is the largest at 72% of fiscal 2024 revenue; Diagnostics and Spatial Biology grew fastest, 12% a year over 7 years.
By product, Consumables is the largest at 81% of fiscal 2026 revenue; Services grew fastest, 17% a year over 9 years.
Revenue by segment
Fiscal years, as Bio-Techne reports them in its 10-K filings; fiscal 2024 total $1.2B.
| Segments | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Share |
|---|---|---|---|---|---|---|---|---|---|
| Protein Sciences | $419M | $482M | $543M | $555M | $705M | $832M | $846M | $831M | 72% |
| Diagnostics and Spatial Biology | $144M | $161M | $172M | $185M | $228M | $275M | $293M | $326M | 28% |
Revenue by product
Fiscal years, as Bio-Techne reports them in its 10-K filings; fiscal 2026 total $1.2B.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | $477M | $535M | $589M | $603M | $752M | $891M | $918M | $928M | $972M | $985M | 81% |
| Instruments | $48M | $62M | $68M | $71M | $94M | $121M | $112M | $108M | $112M | $111M | 9% |
| Services | $24M | $34M | $38M | $47M | $66M | $72M | $86M | $99M | $112M | $94M | 8% |
| Royalty | $15M | $12M | $19M | $17M | $19M | $22M | $21M | $23M | $24M | $25M | 2% |
Revenue by region
Fiscal years, as Bio-Techne reports them in its 10-K filings; fiscal 2026 total $1.2B.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Share |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $313M | $346M | $391M | $404M | $502M | $614M | $642M | $658M | $683M | $635M | 52% |
| EMEA, excluding United Kingdom | $125M | $149M | $156M | $155M | $204M | $219M | $220M | $241M | $266M | $294M | 24% |
| Greater China | $39M | $48M | $58M | $69M | $88M | $112M | $114M | $99M | $100M | $104M | 9% |
| APAC, excluding Greater China | $41M | $48M | $53M | $60M | $69M | $76M | $73M | $74M | $77M | $86M | 7% |
| United Kingdom | $28M | $34M | $35M | $30M | $41M | $49M | $49M | $50M | $55M | $56M | 5% |
| Rest of World | $16M | $18M | $21M | $19M | $27M | $35M | $37M | $36M | $38M | $39M | 3% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for TECH.
Open TECH in InvestinglyQuestions
Where does Bio-Techne make its money?
In fiscal 2024, by segment: Protein Sciences $831M, Diagnostics and Spatial Biology $326M.
From Bio-Techne's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.